Systems and methods for treating cancer
US10449197B2 · kind B2 · utility
1Cited by
0References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 25, 2015 |
| Grant date | Oct 22, 2019 |
| Priority date | — |
| Expiry date | Nov 25, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Embodiments of the invention provide a method of treating cancer, the method comprising providing a subject having cancer cells, and contacting the cancer cells with a therapeutically effective amount of a G2/M checkpoint inhibitor. Embodiments of the invention also provide a method of treating cancer in a subject, the method comprising the steps of: (a) receiving a sample of the cancer cells from the subject; (b) determining if at least a portion of the sample of the cancer cells is LKB 1 deficient; and (c) contacting the cancer cells with a therapeutically effective amount of a G2/M checkpoint inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.